Perceptions and impact of bipolar disorder in Japan: results of an Internet survey

Por Watanabe, Koichiro, Harada, Eiji, Inoue, Takeshi, Tanji, Yuka, Kikuchi, Toshiaki
Publicado no Neuropsychiatr Dis Treat (2016)

Effectiveness of Simple Individual Psychoeducation for Bipolar II Disorder

Por Saito-Tanji, Yuka, Tsujimoto, Emi, Taketani, Reiko, Yamamoto, Ami, Ono, Hisae
Publicado no Case Rep Psychiatry (2016)

Predictors of continuation with olanzapine during the 1-year naturalistic treatment of patients with schizophrenia in Japan

Por Ye, Wenyu, Ascher-Svanum, Haya, Tanji, Yuka, Flynn, Jennifer A, Takahashi, Michihiro
Publicado em 2011

Predictors of antipsychotic monotherapy with olanzapine during a 1-year naturalistic study of schizophrenia patients in Japan

Por Ye, Wenyu, Ascher-Svanum, Haya, Flynn, Jennifer A, Tanji, Yuka, Takahashi, Michihiro
Publicado em 2012

Safety and effectiveness of rapid-acting intra-muscular olanzapine for agitation associated with schizophrenia – Japan postmarketing surveillance study

Por Katagiri, Hideaki, Taketsuna, Masanori, Kondo, Shinpei, Kajimoto, Kenta, Aoi, Etsuko, Tanji, Yuka
Publicado no Neuropsychiatr Dis Treat (2018)

Effectiveness and safety of oral olanzapine treatment transitioned from rapid-acting intramuscular olanzapine for agitation associated with schizophrenia

Por Katagiri, Hideaki, Taketsuna, Masanori, Kondo, Shinpei, Kajimoto, Kenta, Aoi, Etsuko, Tanji, Yuka
Publicado no Neuropsychiatr Dis Treat (2018)

Antipsychotic monotherapy among outpatients with schizophrenia treated with olanzapine or risperidone in Japan: a health care database analysis

Por Ye, Wenyu, Ascher-Svanum, Haya, Tanji, Yuka, Flynn, Jennifer A, Takahashi, Michihiro, Conley, Robert R
Publicado em 2012